
Sign up to save your podcasts
Or


In this episode, Dr. Willem Overwijk returns for a conversation with Dr. Éric Vivier. Dr. Vivier is a professor of immunology at Aix-Marseille and a hospital practitioner at Marseille Public University Hospital. Éric Vivier is also the Chief Scientific Officer at Innate Pharma, a clinical-stage biotech company that creates novel antibodies that activate the immune system to treat patients with cancer. They discuss Dr. Vivier’s scientific background, the importance and the potential of Natural Killer cells, and the next wave of immunotherapy.
By Cambridge Healthtech Institute4.8
2525 ratings
In this episode, Dr. Willem Overwijk returns for a conversation with Dr. Éric Vivier. Dr. Vivier is a professor of immunology at Aix-Marseille and a hospital practitioner at Marseille Public University Hospital. Éric Vivier is also the Chief Scientific Officer at Innate Pharma, a clinical-stage biotech company that creates novel antibodies that activate the immune system to treat patients with cancer. They discuss Dr. Vivier’s scientific background, the importance and the potential of Natural Killer cells, and the next wave of immunotherapy.

43,831 Listeners

32,011 Listeners

30,711 Listeners

1,834 Listeners

112,426 Listeners

125 Listeners

9,530 Listeners

320 Listeners

6,094 Listeners

6,444 Listeners

6,394 Listeners

34 Listeners

5,520 Listeners

18 Listeners

13 Listeners